CABA APS: Financial statements 2021
CVR: 39691825
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
CABA APS (CVR 39691825) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -3,125 and a net result of DKK -3,125 compared with DKK -3,125 the year before. Equity in the 2021 report amounted to DKK 37,500. The solvency ratio was 75%.
- Gross Profit
- DKK -3,125
- Profit/Loss
- DKK -3,125
- Equity
- DKK 37,500
- Total Assets
- DKK 50,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -3 t. | -3 t. | 38 t. | 0 |
| 2020 | - | -3 t. | -3 t. | 41 t. | 0 |
| 2019 | - | -3 t. | -3 t. | 44 t. | 0 |
Find more companies like CABA APS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
CABA APS has published its annual report for 2020. Gross profit came to DKK -3,125, and the net result was DKK -3,125.
As of June 30, 2021, MBA STATSAUTORISERET REVISIONSANPARTSSELSKAB has stepped down as auditor of CABA APS.
About CABA APS
CABA APS is a Danish company of the type Anpartsselskab based in Fårevejle, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ACBA APS. The management consists of Henrik Nakskov and Søren Luplau-Pagh. The company is owned by Devopharma ApS. In 2025, the company reported a gross profit of DKK -3,125 and a net result of DKK -3,125 compared with DKK -3,125 the year before. Equity in the 2025 report amounted to DKK 25,000.